Volitionrx (VNRX) Long-Term Deferred Tax (2021 - 2025)
Volitionrx's Long-Term Deferred Tax history spans 3 years, with the latest figure at $49.8 million for Q4 2025.
- For Q4 2025, Long-Term Deferred Tax rose 18.85% year-over-year to $49.8 million; the TTM value through Dec 2025 reached $49.8 million, up 18.85%, while the annual FY2025 figure was $49.8 million, 18.85% up from the prior year.
- Long-Term Deferred Tax reached $49.8 million in Q4 2025 per VNRX's latest filing, up from $41.9 million in the prior quarter.
- In the past five years, Long-Term Deferred Tax ranged from a high of $49.8 million in Q4 2025 to a low of $25.3 million in Q4 2021.
- Average Long-Term Deferred Tax over 3 years is $39.0 million, with a median of $41.9 million recorded in 2024.
- The largest YoY upside for Long-Term Deferred Tax was 18.85% in 2025 against a maximum downside of 18.85% in 2025.
- A 3-year view of Long-Term Deferred Tax shows it stood at $25.3 million in 2021, then surged by 65.64% to $41.9 million in 2024, then increased by 18.85% to $49.8 million in 2025.
- Per Business Quant, the three most recent readings for VNRX's Long-Term Deferred Tax are $49.8 million (Q4 2025), $41.9 million (Q4 2024), and $25.3 million (Q4 2021).